Lumexa Imaging (NASDAQ:LMRI) Stock Price Up 10.5% – Time to Buy?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price rose 10.5% during trading on Wednesday . The company traded as high as $9.25 and last traded at $9.50. Approximately 80,066 shares were traded during trading, a decline of 90% from the average daily volume of 821,397 shares. The stock had previously closed at $8.60.

Analysts Set New Price Targets

Separately, Raymond James Financial upgraded Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective for the company in a report on Monday, February 9th. One analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the company presently has an average rating of “Strong Buy” and an average price target of $23.00.

Lumexa Imaging Stock Up 9.5%

The company has a 50 day moving average of $13.10.

Lumexa Imaging (NASDAQ:LMRI) last released its earnings results on Thursday, March 26th. The company reported ($0.66) earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.71). The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $262.72 million.

Hedge Funds Weigh In On Lumexa Imaging

Hedge funds have recently bought and sold shares of the company. Assetmark Inc. acquired a new stake in Lumexa Imaging during the 4th quarter worth about $36,000. Barclays PLC acquired a new position in shares of Lumexa Imaging in the 4th quarter valued at about $133,000. Sandia Investment Management LP bought a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $185,000. Hudson Bay Capital Management LP bought a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $237,000. Finally, Oxford Asset Management LLP acquired a new stake in Lumexa Imaging during the fourth quarter worth approximately $670,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).